Paratek Pharmaceuticals, Inc.
Symbol: PRTK
NASDAQ
2.23
USDMarktpreis heute
-3.0521
P/E-Verhältnis
0.1791
PEG-Verhältnis
127.83M
MRK Kapital
- 0.00%
DIV Rendite
Paratek Pharmaceuticals, Inc. (PRTK) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 178.97 | 34.2 | 95.5 | 125.2 | |||||||||||||||||||||
balance-sheet.row.short-term-investments | 29.92 | 0 | 15.1 | 20 | |||||||||||||||||||||
balance-sheet.row.net-receivables | 190.45 | 78 | 33.1 | 15.7 | |||||||||||||||||||||
balance-sheet.row.inventory | 62.72 | 16.6 | 11 | 14.6 | |||||||||||||||||||||
balance-sheet.row.other-current-assets | 41.91 | 7.9 | 12.4 | 7.8 | |||||||||||||||||||||
balance-sheet.row.total-current-assets | 474.42 | 136.8 | 152.1 | 164.1 | |||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 8.63 | 2.4 | 2.6 | 3 | |||||||||||||||||||||
balance-sheet.row.goodwill | 3.32 | 0.8 | 0.8 | 0.8 | |||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 3.32 | 0.8 | 0.8 | 0.8 | |||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 140.11 | 32.5 | 28.4 | 8.9 | |||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 152.06 | 35.7 | 31.8 | 12.7 | |||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-assets | 626.48 | 172.5 | 183.9 | 176.9 | |||||||||||||||||||||
balance-sheet.row.account-payables | 21.68 | 5.3 | 5.4 | 1.8 | |||||||||||||||||||||
balance-sheet.row.short-term-debt | 164.04 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 872.3 | 258.4 | 255.7 | 252 | |||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||
balance-sheet.row.other-current-liab | 91.2 | 32.1 | 25.9 | 22.1 | |||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 1042.35 | 306.2 | 280.4 | 255.2 | |||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 4.89 | 1.5 | 1.3 | 1.5 | |||||||||||||||||||||
balance-sheet.row.total-liab | 1354.08 | 343.6 | 311.7 | 279.1 | |||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.common-stock | 0.23 | 0.1 | 0.1 | 705.5 | |||||||||||||||||||||
balance-sheet.row.retained-earnings | -3769.48 | -930.4 | -866.9 | -807.8 | |||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -0.12 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 3041.77 | 759.4 | 739.1 | 0 | |||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | -727.6 | -171 | -127.8 | -102.3 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 626.48 | 172.5 | 183.9 | 176.8 | |||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-equity | -727.6 | -171 | -127.8 | -102.3 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 626.48 | - | - | - | |||||||||||||||||||||
Total Investments | 29.92 | 0 | 15.1 | 20 | |||||||||||||||||||||
balance-sheet.row.total-debt | 1036.34 | 258.4 | 255.7 | 252 | |||||||||||||||||||||
balance-sheet.row.net-debt | 887.3 | 224.2 | 175.4 | 146.9 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -62.73 | -63.6 | -59.1 | -96.5 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0.31 | 0.5 | 0.4 | 0.6 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 1.1 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 10.34 | 12.3 | 14.3 | 10.2 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | 23.96 | -20.8 | -8.2 | -20.3 | |||||||||||||||||||
cash-flows.row.account-receivables | -5.71 | -40.4 | -21.8 | -7.5 | |||||||||||||||||||
cash-flows.row.inventory | -2.05 | -9.1 | -15.5 | -11.8 | |||||||||||||||||||
cash-flows.row.account-payables | 8.96 | 7.7 | 6.8 | 1.6 | |||||||||||||||||||
cash-flows.row.other-working-capital | 22.76 | 21 | 22.3 | -2.6 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 4.91 | 5.4 | 4.3 | 1.5 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -23.22 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.07 | 0 | -0.4 | -0.4 | |||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | -15.16 | -15.2 | -15.1 | -29.6 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 30 | 30 | 20 | 122.5 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 15.2 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 29.97 | 14.8 | 4.5 | 92.5 | |||||||||||||||||||
cash-flows.row.debt-repayment | -3.73 | -2.9 | -0.3 | -70 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 7.3 | 18.4 | 21.9 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.other-financing-activites | -0.12 | 0.7 | 0.3 | 59.4 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -3.57 | 5.1 | 18.3 | 11.3 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 3.18 | -46.2 | -25.4 | 0.4 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 149.55 | 34.4 | 80.6 | 106 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 146.37 | 80.6 | 106 | 105.6 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | -23.22 | -66.1 | -48.3 | -103.4 | |||||||||||||||||||
cash-flows.row.capital-expenditure | -0.07 | 0 | -0.4 | -0.4 | |||||||||||||||||||
cash-flows.row.free-cash-flow | -23.29 | -66.2 | -48.6 | -103.8 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 167.74 | 150.8 | 121 | 43.5 | ||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 25.3 | 23.1 | 21.5 | 8.7 | ||||||||||||||||||||||
income-statement-row.row.gross-profit | 142.45 | 127.7 | 99.4 | 34.9 | ||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
income-statement-row.row.research-development | 38.83 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.other-expenses | -7.38 | -9.5 | -9.2 | -3.4 | ||||||||||||||||||||||
income-statement-row.row.operating-expenses | 186.99 | 173.9 | 140.5 | 110.4 | ||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 212.29 | 197 | 162.1 | 119 | ||||||||||||||||||||||
income-statement-row.row.interest-income | 0.99 | 0.8 | 0.1 | 1.5 | ||||||||||||||||||||||
income-statement-row.row.interest-expense | 18.86 | 18.1 | 17.4 | 20.2 | ||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -12.98 | -17.3 | -17.4 | -21 | ||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -7.38 | -9.5 | -9.2 | -3.4 | ||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -12.98 | -17.3 | -17.4 | -21 | ||||||||||||||||||||||
income-statement-row.row.interest-expense | 18.86 | 18.1 | 17.4 | 20.2 | ||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0.95 | 1.3 | 0.4 | 1.6 | ||||||||||||||||||||||
income-statement-row.row.ebitda-caps | -43.4 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.operating-income | -44.54 | -46.2 | -41.1 | -75.5 | ||||||||||||||||||||||
income-statement-row.row.income-before-tax | -62.56 | -63.5 | -58.5 | -96.5 | ||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 4.56 | 0.1 | 0.6 | 19.7 | ||||||||||||||||||||||
income-statement-row.row.net-income | -67.12 | -63.6 | -59.1 | -116.3 |
Häufig gestellte Frage
Wie hoch ist die Paratek Pharmaceuticals, Inc. (PRTK) Gesamtvermögen?
Paratek Pharmaceuticals, Inc. (PRTK) Gesamtvermögen ist 172538000.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist 67270000.000.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.850.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist -0.190.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist -0.299.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist -0.201.
Was ist der Paratek Pharmaceuticals, Inc. (PRTK) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist -63566000.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 258414000.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 173941000.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 42685000.000.